Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Grant/Award of 100,000 INMB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Inmune Bio, Inc. (INMB) | Grant/Award | 100,000 | n/a |
| Jun 3, 2026 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 235,000 | n/a |
| Jul 15, 2025 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/Award | 11,066 | n/a |
| Sep 30, 2024 | Onconetix, Inc. (ONCO) | Grant/Award | 3,318 | n/a |
| Jul 19, 2024 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/Award | 132 | n/a |
| Jul 3, 2024 | Entero Therapeutics, Inc. (ENTO) | Sale | 1,289 | $1.4K |
| Jun 27, 2024 | RENOVARO INC. (RENB) | Grant/Award | 48,137 | n/a |
| Apr 3, 2024 | First Wave BioPharma, Inc. (FWBI) | Sale | 174 | $735.92 |
| Mar 19, 2024 | First Wave BioPharma, Inc. (FWBI) | Sale | 1,887 | $9.4K |
| Mar 19, 2024 | RENOVARO INC. (RENB) | Grant/Award | 28,196 | n/a |